Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cancer of Liver

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Cancer of Liver in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chen, L; Chen, MH; He, Q; Jumai, N; Lin, Y; Liu, M; Luo, Y; Wang, Y; Zeng, Z; Zhang, N; Zhang, X1
Chen, X; Deng, H; Huang, Y; Ou, L; Song, Y; Wang, Y; Zhou, Y1
Cha, S; Ehman, EC; Hope, TA; Johnson, GB; Larson, PEZ; Leynes, AP; Villanueva-Meyer, JE1
Jin, Y; Tian, J; Wang, K1
Roesch, F1
Baum, RP; Müller, D; Senftleben, S; Wehrmann, C; Zachert, C1

Reviews

1 review(s) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cancer of Liver

ArticleYear
PET/MRI: Where might it replace PET/CT?
    Journal of magnetic resonance imaging : JMRI, 2017, Volume: 46, Issue:5

    Topics: Adult; Aged; Cohort Studies; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Infections; Inflammation; Liver Neoplasms; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology; Reproducibility of Results

2017

Other Studies

5 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Cancer of Liver

ArticleYear
The role of quantitative tumor burden based on [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:2

    Topics: Humans; Ki-67 Antigen; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Receptors, Somatostatin; Tumor Burden

2023
[
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:5

    Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines

2023
Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
    Bioconjugate chemistry, 2018, 04-18, Volume: 29, Issue:4

    Topics: Animals; Carcinoma, Hepatocellular; Coloring Agents; Contrast Media; Gadolinium; Hep G2 Cells; Heterocyclic Compounds, 1-Ring; Humans; Infrared Rays; Liver Neoplasms; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Optical Imaging; Peptides; Preoperative Period

2018
Scandium-44: benefits of a long-lived PET radionuclide available from the (44)Ti/(44)Sc generator system.
    Current radiopharmaceuticals, 2012, Volume: 5, Issue:3

    Topics: Adsorption; Animals; Cation Exchange Resins; Chelating Agents; Drug Stability; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Nickel; Nuclear Reactors; Positron-Emission Tomography; Puromycin; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Scandium; Titanium; Transplantation, Heterologous

2012
Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC.
    Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:3

    Topics: Adult; Aged; Bone Neoplasms; Female; Heterocyclic Compounds, 1-Ring; Humans; Liver Neoplasms; Lutetium; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radioisotopes; Radiotherapy; Radiotherapy Dosage; Receptors, Peptide; Tomography, X-Ray Computed

2007